Aethlon Medical Stock Total Debt
| AEMD Stock | USD 1.46 0.04 2.82% |
Aethlon Medical fundamentals help investors to digest information that contributes to Aethlon Medical's financial success or failures. It also enables traders to predict the movement of Aethlon Stock. The fundamental analysis module provides a way to measure Aethlon Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aethlon Medical stock.
The current year's Total Debt To Capitalization is expected to grow to 0.07. Aethlon | Total Debt |
Aethlon Medical Company Total Debt Analysis
Aethlon Medical's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Aethlon Medical Total Debt | 1.21 M |
Most of Aethlon Medical's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aethlon Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Aethlon Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for Aethlon Medical is extremely important. It helps to project a fair market value of Aethlon Stock properly, considering its historical fundamentals such as Total Debt. Since Aethlon Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aethlon Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aethlon Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Aethlon Total Debt Historical Pattern
Today, most investors in Aethlon Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Aethlon Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Aethlon Medical total debt as a starting point in their analysis.
Aethlon Medical Total Debt |
| Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Aethlon Net Debt
Net Debt |
|
Based on the latest financial disclosure, Aethlon Medical has a Total Debt of 1.21 M. This is 99.96% lower than that of the Health Care Equipment & Supplies sector and 99.93% lower than that of the Health Care industry. The total debt for all United States stocks is 99.98% higher than that of the company.
Aethlon Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aethlon Medical's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aethlon Medical could also be used in its relative valuation, which is a method of valuing Aethlon Medical by comparing valuation metrics of similar companies.Aethlon Medical is currently under evaluation in total debt category among related companies.
Aethlon Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Aethlon Medical from analyzing Aethlon Medical's financial statements. These drivers represent accounts that assess Aethlon Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Aethlon Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 5.2M | 24.5M | 21.5M | 7.8M | 9.0M | 8.5M | |
| Enterprise Value | (4.3M) | 14.7M | 5.2M | (5.5M) | (6.3M) | (6.0M) |
Aethlon Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Aethlon Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Aethlon Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Aethlon Medical's value.| Shares | Bartlett & Co Wealth Management Llc | 2023-12-31 | 26.0 | Susquehanna International Group, Llp | 2023-09-30 | 0.0 | Larson Financial Group, Llc | 2023-09-30 | 0.0 | Mercer Global Advisors Inc. | 2023-09-30 | 0.0 | Virtu Financial Llc | 2023-09-30 | 0.0 | Vanguard Group Inc | 2023-12-31 | 21.2 K | Geode Capital Management, Llc | 2023-12-31 | 20.3 K | Blackrock Inc | 2023-12-31 | 7.3 K | Group One Trading, Lp | 2023-12-31 | 1.3 K | Tower Research Capital Llc | 2023-12-31 | 1.1 K | Advisor Group Holdings, Inc. | 2023-12-31 | 299 |
Aethlon Fundamentals
| Return On Equity | -0.98 | ||||
| Return On Asset | -0.47 | ||||
| Operating Margin | (20.47) % | ||||
| Current Valuation | (3.14 M) | ||||
| Shares Outstanding | 2.63 M | ||||
| Shares Owned By Insiders | 6.43 % | ||||
| Shares Owned By Institutions | 1.98 % | ||||
| Number Of Shares Shorted | 18.92 K | ||||
| Price To Earning | (1.14) X | ||||
| Price To Book | 0.52 X | ||||
| Price To Sales | 6.91 X | ||||
| Revenue | 574.25 K | ||||
| Gross Profit | 574.25 K | ||||
| EBITDA | (11.76 M) | ||||
| Net Income | (12.03 M) | ||||
| Cash And Equivalents | 14.92 M | ||||
| Cash Per Share | 0.65 X | ||||
| Total Debt | 1.21 M | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 9.66 X | ||||
| Book Value Per Share | 2.93 X | ||||
| Cash Flow From Operations | (10.51 M) | ||||
| Short Ratio | 1.81 X | ||||
| Earnings Per Share | (5.01) X | ||||
| Target Price | 25.0 | ||||
| Number Of Employees | 15 | ||||
| Beta | 1.94 | ||||
| Market Capitalization | 3.84 M | ||||
| Total Asset | 17.51 M | ||||
| Retained Earnings | (142.36 M) | ||||
| Working Capital | 13.59 M | ||||
| Current Asset | 817 K | ||||
| Current Liabilities | 1.08 M | ||||
| Net Asset | 17.51 M |
About Aethlon Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aethlon Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aethlon Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aethlon Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Aethlon Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aethlon Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aethlon Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with Aethlon Stock
| 0.7 | GH | Guardant Health Upward Rally | PairCorr |
Moving against Aethlon Stock
| 0.59 | AGTI | Agiliti Financial Report 14th of May 2024 | PairCorr |
| 0.57 | HQY | HealthEquity Financial Report 3rd of June 2024 | PairCorr |
The ability to find closely correlated positions to Aethlon Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aethlon Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aethlon Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aethlon Medical to buy it.
The correlation of Aethlon Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aethlon Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aethlon Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aethlon Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Aethlon Medical Piotroski F Score and Aethlon Medical Altman Z Score analysis. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Aethlon Stock analysis
When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Aethlon Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.01) | Revenue Per Share 0.236 | Quarterly Revenue Growth 42.782 | Return On Assets (0.47) | Return On Equity (0.98) |
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.